Pharmaniaga Bhd (XKLS:7081) Cyclically Adjusted FCF per Share: RM-0.08 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7081 Pharmaniaga Bhd XKLS:7081
67 GF Score
Price RM1.16
GF Value RM1.12
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd Cyclically Adjusted FCF per Share?

Pharmaniaga Bhd XKLS:7081 -0.85% 67 Cyclically Adjusted FCF per Share is RM-0.08 as of Jun. 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 67/100 and a GF Value™ of RM1.12 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pharmaniaga Bhd's adjusted free cash flow per share for the three months ended in Jun. 2026 was RM-0.136. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is RM-0.08 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -54.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pharmaniaga Bhd was -54.20% per year. The lowest was -54.20% per year. And the median was -54.20% per year.

As of today (2026-08-29), Pharmaniaga Bhd's current stock price is RM1.16. Pharmaniaga Bhd's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was RM-0.08. Pharmaniaga Bhd's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharmaniaga Bhd was 251.17. The lowest was 214.02. And the median was 242.26.


Pharmaniaga Bhd  (XKLS:7081) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharmaniaga Bhd was 251.17. The lowest was 214.02. And the median was 242.26.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pharmaniaga Bhd Cyclically Adjusted FCF per Share Related Terms


Pharmaniaga Bhd Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Pharmaniaga Bhd's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaniaga Bhd Cyclically Adjusted FCF per Share Chart

Pharmaniaga Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.03 -0.09 -0.13 -0.11

Pharmaniaga Bhd Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.08 -0.11 -0.07 -0.08

XKLS:7081 vs MCK, COR, CAH: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Pharmaniaga Bhd's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaniaga Bhd Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Cyclically Adjusted Price-to-FCF falls into.


XKLS:7081
67GF Score
Pharmaniaga Bhd XKLS:7081
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaniaga Bhd Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharmaniaga Bhd's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.136/333.9520*333.9520
=-0.136

Current CPI (Jun. 2026) = 333.9520.

Pharmaniaga Bhd Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.059 241.428 -0.082
201612 0.255 241.432 0.353
201703 0.078 243.801 0.107
201706 -0.002 244.955 -0.003
201709 -0.089 246.819 -0.120
201712 0.380 246.524 0.515
201803 -0.463 249.554 -0.620
201806 -0.012 251.989 -0.016
201809 -0.185 252.439 -0.245
201812 0.305 251.233 0.405
201903 0.115 254.202 0.151
201906 -0.164 256.143 -0.214
201909 -0.013 256.759 -0.017
201912 0.326 256.974 0.424
202003 -0.199 258.115 -0.257
202006 -0.007 257.797 -0.009
202009 -0.122 260.280 -0.157
202012 0.195 260.474 0.250
202103 -0.222 264.877 -0.280
202106 -0.746 271.696 -0.917
202109 0.768 274.310 0.935
202112 -0.049 278.802 -0.059
202203 -0.029 287.504 -0.034
202206 -0.361 296.311 -0.407
202209 0.018 296.808 0.020
202212 -0.127 296.797 -0.143
202303 -0.160 301.836 -0.177
202306 0.218 305.109 0.239
202309 -0.100 307.789 -0.109
202312 -0.015 306.746 -0.016
202403 -0.132 312.332 -0.141
202406 -0.037 314.175 -0.039
202409 -0.016 315.301 -0.017
202412 0.191 315.605 0.202
202503 0.037 319.799 0.039
202506 -0.013 322.561 -0.013
202509 -0.284 324.800 -0.292
202512 0.113 324.054 0.116
202603 -0.019 330.213 -0.019
202606 -0.136 333.952 -0.136

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of RM-0.08 mean?
Pharmaniaga Bhd (XKLS:7081) has a Cyclically Adjusted FCF per Share of RM-0.08 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pharmaniaga Bhd and its competitors.
Is Pharmaniaga Bhd's Cyclically Adjusted FCF per Share too high?
Pharmaniaga Bhd's current Cyclically Adjusted FCF per Share is RM-0.08. Overall, Pharmaniaga Bhd has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Cyclically Adjusted FCF per Share compare to MCK and COR?
Pharmaniaga Bhd's Cyclically Adjusted FCF per Share of RM-0.08 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current Cyclically Adjusted FCF per Share is RM-0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Fairly Valued. The stock's GF Value™ is RM1.12, compared to a current price of RM1.16 — trading 3.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is RM-0.08. Pharmaniaga Bhd's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Cyclically Adjusted FCF per Share is RM-0.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.16 is trading 3.6% above its estimated GF Value™ of RM1.12. GuruFocus considers Pharmaniaga Bhd to be Fairly Valued.

Key valuation signals for XKLS:7081:

  • Cyclically Adjusted FCF per Share: RM-0.08
  • GF Value™: RM1.12 vs. price of RM1.16 (3.6% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
67GF Score

Get the complete analysis for XKLS:7081

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.16
Price
RM1.12
GF Value